AUGX Augmedix
- 2.710
- +0.050+1.88%
Augmedix News
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following
Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024
SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market
Augmedix, Inc.'s (NASDAQ:AUGX) 29% Cheaper Price Remains In Tune With Revenues
Unfortunately for some shareholders, the Augmedix, Inc. (NASDAQ:AUGX) share price has dived 29% in the last thirty days, prolonging recent pain. Longer-term shareholders would now have taken a real
Augmedix Awarded on Newsweek's World's Best Digital Health Companies 2024 List
Lake Street Sticks to Its Buy Rating for Augmedix (AUGX)
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency
Augmedix(AUGX.US) Officer Sells US$1,900 in Common Stock
$Augmedix(AUGX.US)$ Officer Shakil Ian sold 500 shares of common stock on Apr 15, 2024 at an average price of $3.8 for a total value of $1,900.Source: Announcement What is statement of changes in bene
Augmedix(AUGX.US) Officer Sells US$74,589.68 in Common Stock
$Augmedix(AUGX.US)$ Officer Shakil Ian sold 19,544 shares of common stock on Apr 12, 2024 at an average price of $3.8165 for a total value of $74,589.68.Source: Announcement What is statement of chang
Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing
Ian Shakil, Director, CHIEF STRATEGY OFFICER, around April 09, 2024, sold 92,787 shares in Augmedix (AUGX) for $369,285. Following the Form 4 filing with the SEC, Shakil has control over a total of 3,
Insider Sell: Augmedix Inc's (AUGX) Chief Strategy Officer Ian Shakil Sells 92,787 Shares
Augmedix(AUGX.US) Officer Sells US$369.29K in Common Stock
$Augmedix(AUGX.US)$ Officer Shakil Ian sold 92,787 shares of common stock on Apr 9, 10, 11, 2024 at an average price of $3.9799 for a total value of $369.29K.Source: Announcement What is statement of
Augmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 89,167 Shares
(SEC Amendment) Augmedix(AUGX.US) Officer Sells US$129.85K in Common Stock
$Augmedix(AUGX.US)$ Officer Shakil Ian sold 31,994 shares of common stock on Mar 28, 2024 at an average price of $4.0586 for a total value of $129.85K.Source: Announcement What is statement of changes
Augmedix(AUGX.US) Officer Sells US$357.2K in Common Stock
$Augmedix(AUGX.US)$ Officer Shakil Ian sold 89,167 shares of common stock on Apr 5, 8, 2024 at an average price of $4.006 for a total value of $357.2K.Source: Announcement What is statement of changes
Augmedix Raised to Outperform From In-Line by Evercore ISI Group
Augmedix Raised to Outperform From In-Line by Evercore ISI Group
Augmedix Price Target Raised to $5.00/Share From $4.50 by Evercore ISI Group
Augmedix Price Target Raised to $5.00/Share From $4.50 by Evercore ISI Group
Evercore ISI Group: The Augmedix (AUGX.US) rating was raised simultaneously from the market to superior to the market rating, and the target price was adjusted from $4.50 to $5.00.
Evercore ISI Group: The Augmedix (AUGX.US) rating was raised simultaneously from the market to superior to the market rating, and the target price was adjusted from $4.50 to $5.00.
Evercore ISI Group Upgrades Augmedix to Outperform, Raises Price Target to $5
Evercore ISI Group analyst Elizabeth Anderson upgrades Augmedix (NASDAQ:AUGX) from In-Line to Outperform and raises the price target from $4.5 to $5.
Augmedix Integrates With Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (NASDAQ:AUGX), a leader in ambient AI
Form 144 | Augmedix(AUGX.US) Director Proposes to Sell 1.21 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 8, $Augmedix(AUGX.US)$ Director IAN SHAKIL intends to sell 300K shares of its common stock on Apr 8, with a total market value of approximately $1.21 million. IAN SHAKIL
Analysis
Price Target
No Data
